| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2139 | 2003 |
| Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy G Giordano, F Blanchini, R Bruno, P Colaneri, A Di Filippo, A Di Matteo, ... Nature medicine 26 (6), 855-860, 2020 | 1997 | 2020 |
| Remdesivir for 5 or 10 days in patients with severe Covid-19 JD Goldman, DCB Lye, DS Hui, KM Marks, R Bruno, R Montejano, ... New England Journal of Medicine 383 (19), 1827-1837, 2020 | 1712 | 2020 |
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study Data Collection on Adverse Events of Anti-HIV Drugs Study Group Archives of internal medicine 166 (15), 1632-1641, 2006 | 1514 | 2006 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review R Castagnoli, M Votto, A Licari, I Brambilla, R Bruno, S Perlini, F Rovida, ... JAMA pediatrics 174 (9), 882-889, 2020 | 1425 | 2020 |
| Myocardial localization of coronavirus in COVID‐19 cardiogenic shock G Tavazzi, C Pellegrini, M Maurelli, M Belliato, F Sciutti, A Bottazzi, ... European journal of heart failure 22 (5), 911-915, 2020 | 1143 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 853 | 2021 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 544 | 2021 |
| Update of the statements on biology and clinical impact of occult hepatitis B virus infection G Raimondo, S Locarnini, T Pollicino, M Levrero, F Zoulim, AS Lok, ... Journal of hepatology 71 (2), 397-408, 2019 | 431 | 2019 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 391 | 2021 |
| Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic … R Caccialanza, A Laviano, F Lobascio, E Montagna, R Bruno, S Ludovisi, ... Nutrition 74, 110835, 2020 | 350 | 2020 |
| Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome M Puoti, R Bruno, V Soriano, F Donato, GB Gaeta, GP Quinzan, ... Aids 18 (17), 2285-2293, 2004 | 325 | 2004 |
| European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults JK Rockstroh, S Bhagani, Y Benhamou, R Bruno, S Mauss, L Peters, ... HIV medicine 9 (2), 82-88, 2008 | 320 | 2008 |
| Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome C Gazzaruso, R Bruno, A Garzaniti, S Giordanetti, P Fratino, P Sacchi, ... Journal of hypertension 21 (7), 1377-1382, 2003 | 313 | 2003 |
| Whole-genome sequencing reveals host factors underlying critical COVID-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature 607 (7917), 97-103, 2022 | 310 | 2022 |
| Natural history of chronic hepatitis B in co-infected patients M Puoti, C Torti, R Bruno, G Filice, G Carosi Journal of hepatology 44, S65-S70, 2006 | 309 | 2006 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 295 | 2005 |
| Prophylaxis and treatment of hepatitis B in immunocompromised patients A Marzano, E Angelucci, P Andreone, M Brunetto, R Bruno, P Burra, ... Digestive and Liver Disease 39 (5), 397-408, 2007 | 286 | 2007 |
| Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department I Cassaniti, F Novazzi, F Giardina, F Salinaro, M Sachs, S Perlini, R Bruno, ... Journal of medical virology 92 (10), 1724, 2020 | 282 | 2020 |
| Unique immunological profile in patients with COVID-19 S Varchetta, D Mele, B Oliviero, S Mantovani, S Ludovisi, A Cerino, ... Cellular & molecular immunology 18 (3), 604-612, 2021 | 277 | 2021 |
Antonio CraxiFull Professor of Gastroenterology and Internal Medicine, PROMISE, University of Palermo, ItalyVahvistettu sähköpostiosoite verkkotunnuksessa unipa.it